EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

The roles of RGS proteins in cardiometabolic disease

Samantha M McNeill, Peishen Zhao

British Journal of Pharmacology · 2024

DOI: 10.1111/bph.16076 ↗

At a glance

Übersichtsarbeit in British Journal of Pharmacology, 2024. Written by Samantha M McNeill and 1 co-authors. Institution: Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia. Major MEDLINE topics: RGS Proteins, Receptors, G-Protein-Coupled. Cited 4 times so far (Crossref); 155 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Australian Research Council.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

G protein‐coupled receptors (GPCRs) are the most prominent receptors on the surface of the cell and play a central role in the regulation of cardiac and metabolic functions. GPCRs transmit extracellular stimuli to the interior of the cells by activating one or more heterotrimeric G proteins. The duration and intensity of G protein‐mediated signalling are tightly controlled by a large array of intracellular mediators, including the regulator of G protein signalling (RGS) proteins. RGS proteins selectively promote the GTPase activity of a subset of Gα subunits, thus serving as negative regulators in a pathway‐dependent manner. In the current review, we summarise the involvement of RGS proteins in cardiometabolic function with a focus on their tissue distribution, mechanisms of action and dysregulation under various disease conditions. We also discuss the potential therapeutic applications for targeting RGS proteins in treating cardiometabolic conditions and current progress in developing RGS modulators. LINKED ARTICLES This article is part of a themed issue Therapeutic Targeting of G Protein‐Coupled Receptors: hot topics from the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists 2021 Virtual Annual Scientific Meeting. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v181.14/issuetoc

Subjects

MeSH terms (MEDLINE)

RGS ProteinsReceptors, G-Protein-CoupledHumansAnimalsCardiovascular DiseasesMetabolic DiseasesSignal Transduction

Author keywords

GPCR signallingRGS proteinscardiometabolic diseasedrug design

Substances

RGS ProteinsReceptors, G-Protein-Coupled

Authors and institutions

  • Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • ARC Centre for Cryo-Electron Microscopy of Membrane Proteins (CCeMMP), Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.

Funding

  • Australian Research Council

Cite

APA

McNeill, S. M., & Zhao, P. (2024). The roles of RGS proteins in cardiometabolic disease. British Journal of Pharmacology. https://doi.org/10.1111/bph.16076

Vancouver

McNeill SM, Zhao P. The roles of RGS proteins in cardiometabolic disease. British Journal of Pharmacology. 2024. doi:10.1111/bph.16076

BibTeX
@article{McNeill2024,
  author = {McNeill, Samantha M and Zhao, Peishen},
  title = {The roles of RGS proteins in cardiometabolic disease},
  journal = {British Journal of Pharmacology},
  year = {2024},
  doi = {10.1111/bph.16076}
}
Start for free →